Breaking Free From HAE - Machelle’s Story

Machelle’s first experience with HAE was when she was about 3 years old, but she wasn’t officially diagnosed until she was 21. Determined to better manage her HAE, she participated in a clinical trial for HAEGARDA®, C1 Esterase Inhibitor Subcutaneous (Human). With HAEGARDA Machelle is now preventing her attacks and she is able to spend more time with her family and become a powerful voice of inspiration for the HAE community.
Please see full Important Safety Information at the end of this video, and view the full Prescribing Information here: bit.ly/HGD-PI
Please subscribe to the HAEGARDA RUclips channel here: bit.ly/2CDfuEW
View the HAEGARDA Facebook page here: / haegarda